Media & Announcements
Polpharma Group at CPHI Milan 2026: Strengthening Partnerships Across the Global Pharmaceutical Value Chain
At CPHI Milan 2026, a Polpharma delegation led by CEO Sebastian Szymanek met partners on APIs, finished dosage forms, CDMO services and new technologies.
Group News
October 21, 2026
Polpharma at EFNI 2026: Building Innovation, Resilience and Europe’s Future
At EFNI 2026 in Sopot, Polpharma shared its innovation experience and joined debates on resilient supply chains and Europe’s industrial future.
Group News
October 21, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
Polpharma Group’s R&D supports growth in key therapeutic areas.
Polpharma Group's research and development capabilities support growth across its key therapeutic areas and strengthen its product pipeline.
Group News
June 26, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
.avif)
.avif)
The Leonardo Innovation Program won the Gold Stevie Awards® gold statuette in the 19th edition of the prestigious international competition International Business Awards®!
The Leonardo employee innovation programme wins Gold at the Stevie International Business Awards for creativity, engagement and innovative communication.
Group News
August 16, 2022
Polpharma API completed step 1. Risk Evaluation according to EMA’s request concerning presence of nitrosamines in drug products.
Polpharma completed EMA risk assessment for nitrosamines in chemically synthesised APIs, identifying optimisation parameters for highest quality.
Group News
December 17, 2020
Press releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Corporate Social Responsibility
Polpharma Group
September 3, 2024
The companies Grupa NEUCA, Polpharma, Adamed Pharma, Teva, and Zentiva have formed a strategic partnership for the first time to promote ESG development in pharmacies.
Polpharma, NEUCA, Adamed Pharma, Teva and Zentiva partner on the Medicines Back to the Pharmacy campaign, educating patients on safe disposal of medicines.
Corporate Social Responsibility
Polpharma Group
July 8, 2024
Polpharma is a supporting partner of a charity campaign for children affected by road accidents — the Huge Expedition of „Maluch” Cars
Polpharma backs the Huge Expedition of Maluch Cars, a charity rally of 80 Fiat 126p cars from Warsaw to Monte Cassino aiding child road accident victims.
Corporate Social Responsibility
Polpharma Group
June 26, 2024
3rd Place in the „ESG Ranking: Responsible Management”
Polpharma ranks third in the pharmaceutical and medical industry in the 18th edition of the ESG Ranking: Responsible Management by Koźminski Business Hub.
Corporate Social Responsibility
Polpharma Group
June 19, 2024
Polpharma was awarded the Silver ESG Leaf by POLITYKA
POLITYKA, Deloitte and the Responsible Business Forum award Polpharma the Silver ESG Leaf for applying ISO 26000 solutions in its daily operations.
Latest stories
featured
.avif)
For the media
Media Kit
Logos, photography and the Group boilerplate.
ZIP file (112.28 kb) updated quarterly
Group factsheet
Revenue, footprint, pipeline, employment and history.
Pdf file (112.28 kb) updated quarterly
Press Contact
Logos, photography and the Group boilerplate.
press@polpharma.com
RESPONDS WITHIN ONE BUSINESS DAY